Generics 23

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Gefitinib manufacturers

23 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

23 products found

gefitinib

Tablets 250mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Manufacturer #9406

Manufacturer usually replies in 7 days

gefitinib

Tablets 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #22283
This company is a leading manufacturer of anti-cancer medications, specializing in a wide range of oncology drugs including those for solid tumors, hematology, and supportive care. They boast a portfolio of over 100 products with a focus on cost-effectiveness through in-house API development and manufacturing. The company's commitment to innovation is evident in their New Drug Delivery System (NDDS) formulations which aim to improve patient compliance and reduce medication waste. Their strong R&D pipeline promises further advancements in the oncology field. They hold WHO-GMP certifications for their API plant, enabling both domestic and international market reach. Key therapy areas include AML, Renal Cell Carcinoma, Gastro-Intestinal tumors, Pancreatic Neuroendocrine Tumors, Thyroid cancer, and Prostate cancer.

Manufacturer usually replies in 4 days

gefitinib

Tablets 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21239

Manufacturer usually replies in 50 days

Want to see all 23 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Gefitinib Manufacturers Gefitinib manufacturers sell this Drug under various Brand names like Gefinter, Gefinor, and Iressa. Gefitinib is available in the form of film-coated tablets with the dosage strength of 250mg, which is administered orally once daily and is absorbed slowly with a mean bioavailability of 60%. The dose is the same for both male and female patients irrespective of age and weight. The approved storage conditions for Gefitinib are to be stored at room temperature 20 C – 25 C (68 F- 77 F) under the original package to protect from moisture. Wholesale Price of Gefitinib In the US region, the price of Gefitinib ranges from $6.5 - $8.6 per pill or unit, and the cost can go up to $229 to $604 for the quantity of 60 to 90 tablets, which are available in Aluminum / PVC perforated, or non-perforated blisters. Gefitinib - Mechanism of Action Gefitinib belongs to the Therapeutic class (a group of medicines) of Antineoplastic agents, which is pharmacologically a Tyrosine kinase inhibitor. Tyrosine Kinase is a type of protein that delivers signals telling cancer cells to grow. Gefitinib works by blocking the action of tyrosine kinase by inhibiting these signals thereby preventing the cancer cells from growing and multiplying. Thus, Gefitinib inhibits EGFR tyrosine kinase by binding to the adenosine triphosphate (ATP) binding site of the enzyme with a protein binding capacity of almost 90%. Finding Gefitinib Manufacturers and Suppliers Many times we tend to find manufacturers and suppliers by attending conferences, exhibitions, etc. that is time-consuming and is directly related to money, and we are not sure whether we get the trusted suppliers, which is a major constraint then. One can avoid this constraint by Pipelinepharma, which helps you in finding the trusted manufacturers and suppliers of Gefitinib. Pipelinepharma, which is a business-to-business (B2B) licensing marketplace for pharmaceutical products that quickly connects the owner with the consumer for business development. You can filter the product names in the unified search engine by its country, category, therapeutic area, forms, dossier, and its status, regulatory filings, approvals, and more.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible